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Highlights 
- Manual therapy and exercise decrease pain and improve physical function. 
- Manual therapy increases range of motion in hip osteoarthritis at short term.  
- Physical therapist could apply patient education and expect positive effects. 
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EFFECTS OF NON-PHARMACOLOGICAL CONSERVATIVE TREATMENT ON 
PAIN, RANGE OF MOTION AND PHYSICAL FUNCTION IN PATIENTS WITH 
MILD TO MODERATE HIP OSTEOARTHRITIS. A SYSTEMATIC REVIEW. 
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ABSTRACT 
Objective: The purpose of this review was to identify the effects of non-pharmacological 
conservative treatment on pain, range of motion and physical function in patients with 
mild to moderate hip osteoarthritis.  
Design: A systematic review based on Preferred Reporting Items for Systematic Reviews 
and Meta-Analysis (PRISMA) guidelines.  
Setting: We searched MEDLINE, PEDro, Scopus and the Cochrane Library databases for 
randomized controlled trials related to non-pharmacological conservative treatments for 
hip osteoarthritis with the following keywords: “hip osteoarthritis,” “therapeutics,” 
“physical therapy modalities,” and “combined physical therapy”. The PEDro scale was 
used for methodological quality assessment and the Oxford Centre of Evidence-Based 
Medicine scale was used to assess the level of evidence. Outcomes measures related to 
pain, hip range of motion and physical function were extracted from these studies. 
Results: Twelve studies met the inclusion criteria. Most of the studies showed high level 
of evidence and only two showed low level of evidence. High quality of evidence showed 
that manual therapy and exercise therapy are effective in improving pain, hip range of 
motion and physical function. However, high quality studies based on combined therapies 
showed controversy in their effects on pain, hip range of motion and physical function.    
Conclusions: Exercise therapy and manual therapy and its combination with patient 
education provides benefits in pain and improvement in physical function. The effects of 
combined therapies remain unclear. Further investigation is necessary to improve the 
knowledge about the effects of non-pharmacological conservative treatments on pain, hip 
range of motion and physical function.  
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1.Introduction 
Hip osteoarthritis (OA) is one of the most common chronic degenerative joint disease in 
the world.1 People suffering from OA are troubled with chronic pain, loss of mobility, 
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stiffness around the hip joint which leads to limitations of daily activities.2,3 The estimated 
prevalence of hip OA is approximately 3.9% for men and 5.1% for women and is 
expected to grow greatly and be a major public health problem in the near future.4 
According to the recommendation of the American College of Rheumatology (ACR), the 
oral drugs are primarily pain treatment. The limitations of these medications include 
gastrointestinal upset and dose dependency.5 Clinical practice guidelines recommend 
non-pharmacological interventions such as manual therapy (MT), therapeutic exercise 
and other conservative techniques as a part of the management of patients with mild to 
moderate hip OA.5–7 These treatments have been proposed with the aim to reduce pain 
and improve hip mobility.  
However, the effects of conservative treatments in patients with mild to moderate hip OA 
are still unclear. There is no evidence of the best treatment for patients diagnosed with 
hip OA with no surgery indications or previous replacements. 
Therefore, we carried out this systematic review with the aim of assessing the 
methodological quality of studies that evaluated non-pharmacological conservative 
treatments in patients with mild to moderate hip OA and determining the effects of the 
published techniques on pain, hip range of motion (ROM) and physical function. The 
information from this review could help the development of rehabilitation programs 
focused on helping these patients, slowing the progression of the disease8 and reducing 
costs.  
 
 
2.Methods 
 
2.1. Design  
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This review has been reported based on Preferred Reporting Items for Systematic 
Reviews and Meta-Analysis (PRISMA) guidelines.9,10 The review protocol was 
registered on the International Prospective Register of Systematic Reviews (PROSPERO) 
with ID CRD42018103864. 
 
2.2. The review question 
Studies were identified from MEDLINE, Physiotherapy Evidence Database (PEDro), 
Cochrane Library and SCOPUS databases. The search was performed using combinations 
of the following Medical Subject Headings (MeSH): “hip osteoarthritis”, “therapeutics”, 
“physical therapy modalities”, “combined physical therapy” linked with the Boolean 
operators of AND and OR and with no limits on publication date. The search strategy is 
shown in detail in Appendix 1.  
 
To be included studies had to meet the following inclusion criteria based on the PICOS 
method: 
- Population: The population of interest was patients with mild to moderate 
hip OA without surgical indications, diagnosed with primary OA according to 
ACR criteria or X-Ray. 
- Intervention: The interventions of interest were non-pharmacological 
conservative treatments. 
- Comparative intervention (Comparison): Comparison interventions of 
interest included other non-pharmacological conservative treatments, sham 
techniques, or no intervention. 
- Outcome(s) of the intervention (Outcome): The studies that measured 
pain, ROM and/or physical function as primary variables using various methods 
were selected.  
- Study design: randomized controlled trials. 
- Language: studies published into the English, French or Spanish language 
were included.  
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 Studies were excluded if they: (1) selected patients with secondary hip OA, previous hip 
surgery, history of congenital /adolescent hip disease; hip pelvic fracture; rheumatoid 
arthritis, ankylosing spondylitis or other rheumatic diseases; or intra-articular hip 
corticosteroid injection within one month; (2) reported patients with musculoskeletal 
disorders such as low back pain, neck pain, knee OA or ankle OA; (3) reported patients 
on waiting list for total hip surgery; (4) used pharmacological or surgical treatment as a 
primary intervention in any group. 
 
2.3. Data collection process 
Two authors independently reviewed the titles and abstracts retrieved from all databases 
and determined if the studies met the inclusion criteria. Eligible full text studies were 
retrieved and screened again by the same reviewers. To be as inclusive as possible, 
reference lists of the identified studies were manually checked for inclusion. A third 
author decided on any disagreement.  
Data were extracted from the studies by the same two reviewers independently, including 
conservative treatment type, single session duration, frequency of the intervention, total 
number of sessions, duration of care, follow up time frame, outcome measures assessing 
pain, ROM and/or function and other secondary outcomes relevant for hip OA such as 
quality of life. 
 
2.4. Data synthesis and analysis 
The PRISMA checklist was used to document the studies and include information on 
study design, sample size, subject characteristics, treatment protocol, dependent 
variables, measurement tools and outcomes measures.  
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Methodological quality of the studies was conducted using PEDro scale checklist. The 
PEDro scale is based on the Delphi list developed by Verhagen and colleagues at the 
Department of Epidemiology, University of Maastricht. The Delphi list is a criteria list 
for quality assessment of clinical trials for conducting systematic reviews developed by 
Delphi consensus.11 This scale has 11 items. A total score out of 10 is derived for each 
study from the number of criteria that are satisfied. A higher score indicates better 
methodological quality. A score of 7 or above was considered to be “high” quality, 5-6 
was considered “fair” quality and 4 or below was considered “poor quality”.12 The PEDro 
scale has shown to be a valid measure of methodological quality of clinical trials and to 
present high internal consistency, (0.53) inter –rater (0.4-0.75) and test – retest (r: 0.99) 
reliability.13  
Also, the Oxford Centre of Evidence-Based Medicine (OCEBM) scale was used to assess 
the level of evidence of each included study. This scale is characterized by making an 
assessment of the evidence based on the thematic area and the type of the study. It has de 
advantage of grading the evidence according to the best design for each clinical 
scenario.14 
Data extraction and study quality were revised independently by the two same authors 
and a third author decided on any disagreement. 
 
 
3. Results 
Initial searches identified 2734 studies (2372 MEDLINE, 267 PEDro, 197 SCOPUS and 
85 Cochrane Library). After eliminating duplicates, the title and the abstract were 
screened and a total of 42 studies were considered relevant to full text screening. Finally, 
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a total of 12 studies that met the inclusion criteria were included. The selection process is 
shown in Figure 1. 
A total of 900 participants were examined in the trials. Marked variability was noted with 
regard to study participants recruited. Most studies recruited between 60 and 152 
participants.15–22 However, 4 studies recruited fewer than 60 participants.23–26 Sample size 
calculation was performed in most of the studies based on determining a minimally 
clinically relevant difference for one or more of the primary outcomes measures.15–17,20–
22,25,26 The studies were done in Europe,15–19,21,25 Asia,23,24,26 America,20 and Oceania.22 
Recruitment of samples varied widely, with studies recruiting from rheumatology 
departments, orthopaedic departments15–17,21,23,24 or private clinics.20,26 Four studies did 
not specify the recruitment.18,19,22,25  The interventions were delivered by physiotherapist 
except for two studies in which the MT intervention was provided by chiropractors.17,20   
 
3.1. Methodological quality assessment 
According to PEDro scale, 10 studies showed high quality with a score of 7 or above,15–
22,25,26 no one presented a fair quality and 2 studies presented a poor quality with a score 
of 4.23,24 The quality ratings are provided in Table 1.  The most part of the studies met the 
criteria for random allocation, similar baseline characteristics between groups, between 
group statistical comparisons and point measures and measures of variability for at least 
one key outcome. Nevertheless, in most studies neither the therapist nor the patients were 
blinded. This is common in most physical therapy trials because of the nature of physical 
therapy intervention.27 Figure 2 provides the risk of bias across studies.   
All the studies showed a level of evidence 1b according to Oxford scale. This level 
corresponds to an advisable level of recommendation, moderate evidence that the 
measure is effective and the benefits are higher than detriments. 
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 3.2. Characteristics of the studies: interventions and outcomes  
Most of the studies used MT, supervised or unsupervised exercise therapy (ET) and 
patient education (PE). Two studies used MT in isolation,15,25 3 used MT combined with 
ET,16,20,22 4 used different types of ET,18,19,23,24 2 used PE combined with MT or ET17,21 
and 1 ET plus ultrasounds (US).26  
The frequency and the total number of sessions varied across all studies. MT sessions 
ranged from 1 to 3 sessions in alternative days when it was applied in isolation.15,25 When 
MT was combined with other techniques, the number of sessions ranged from 4 to 12, 
over 5 to 12 weeks.16,20,22 Studies in which ET was used in isolation the application varied 
widely. In some studies, ET was applied daily for 2 months or 3 times a week for 4 
months, 60 and 48 sessions in total respectively.18,19,23,24 When ET was combined with 
other therapies varied from 6 to 120 sessions over 2 to 9 months.16,20,22 PE consisted of 5 
sessions in both studies.17,21 The only study that used electrotherapy applied US 5 times 
a week for 2 weeks, 10 sessions in total.26 
In relation to the assessment of primary outcomes of the studies, 11 studies assessed pain; 
4 studies used a visual analogic scale (VAS);22–24,26 7 studies used Western Ontario and 
McMaster Universities (WOMAC) pain subscale questionnaire15,16,19–22,26 and 2 studies 
used the numerical rating scale (NRS).16,17 5 studies assessed hip ROM with 
goniometer.15–18,25 8 studies assessed physical function; 6 studies registered physical 
function with WOMAC physical function subscale questionnaire.16,19–22,26 Other physical 
function measures most used were Timed up and go test (TUG)19,23,25 and 30 seconds 
chair to stand (30CS).19,25. Other tests used in the included studies were: timed stairs 
climbing test (TSC), 6 minutes walking test (6MWT), 15 seconds marching on the spot 
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test (MOS), 40 meters self-placed (SPW), five times sit to stand and 50 full walk test, 3 
minutes walking test (3MWT) and 15 m time walking test.16,19,23,25,26  
 
 
3.3. Effects of interventions 
 
3.3.1. Pain 
Two studies showed a high quality of evidence that MT could relieve pain in the short 
term.15,25 High quality of evidence suggested that Nordic Walking (NW) improved pain 
more than supervised or not strength training at 4 months of follow-up.19 Low quality of 
evidence showed unclear outcomes about the effectiveness of low and high velocity 
training to relieve pain.23,24 Low velocity resistance seemed to be more effective than 
high-velocity resistance training.24 High quality evidence suggested that ET was more 
effective combined with hot packs and US at 1 and 3 months of follow-up.26 High quality 
evidence showed that PE combined with MT was effective in reducing pain in the long 
term.17 Three studies showed controversy about combined treatments; MT plus ET did 
not show better benefits than full kinetic chain treatment or ET in isolation or a sham 
treatment.16,20,22 
 
3.3.2. Range of motion 
High quality evidence was presented, showing that MT increased hip ROM in the short-
term.15,25 High quality of evidence suggested that NW seemed to improve ROM more 
than strength training, but without statistical differences between them at 4 months of 
follow-up.18 The combination of MT plus ET did not show better benefits in hip ROM at 
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4 months of follow-up.16 Poulsen et al.,17 did not show differences in hip ROM between 
PE, PE plus MT and a control group.  
 
3.3.3. Function 
High quality of evidence showed that MT could improve physical function immediately 
after treatment.25 ET based on high velocity training seemed to be more effective than 
low velocity training in improving physical function after 8 weeks.23 High quality 
evidence showed that NW had better effects on physical function, measured by TUG test, 
30CS, TSC and MOS, than strengthening or unsupervised exercises at 4 and 12 months 
of follow-up.19 The combination of ET plus PE showed better benefits than PE at 10 and 
16 months of follow-up21 and the combination of ET plus hot packs and US showed better 
benefits than ET at 1 and 3 months of follow-up.26The combination of MT plus PE did 
not show better benefits in physical function at 4 months of follow-up.16 Bennell et al.,22 
showed that MT plus home exercises and PE had no better benefits than a sham technique. 
Brantingham, et al.,20 did not show differences between the application of MT in the hip 
joint or in the entire lower limb.   
Table 2 shows the results of the selected studies. 
 
3.3.4. Effect Size  
Only 4 studies reported effect size results. ET showed a small effect size for reducing 
pain.24 MT reported a large effect size on pain, ROM and physical function.25 PE plus 
MT showed a large effect size on pain but a small effect size on ROM.17 PE plus ET 
showed a small to moderate effect size for reducing pain and disability.21 Results are 
shown in detail in Table 3.  
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4. Discussion 
This systematic review assessed the effects of non-pharmacological conservative 
treatments on pain, hip ROM and physical function in mild to moderate hip OA patients. 
Our review found high quality evidence that MT, ET and MT combined with PE reduced 
pain intensity at post-treatment15,25 and follow-up.17,19,21 The combination of MT and ET 
had shown unclear results about the effects on pain variable.16   
According to the authors of these studies, the improvements of MT could be related to a 
biomechanical and neurophysiological effects. MT might provide an improvement of 
elasticity of the joint capsule and a stretching effect on the muscles surrounding the hip 
joint. In addition, the mechanical stimulus could initiate a physiological response that 
activates the descending pain inhibitory system as well as potentially central pain 
processing mechanism.28,29  
The improvement achieved in pain variable with ET has been explained by two ways. 
One way suggests the systematic desensitization or graded repeated exposure to generate 
a new memory of safety in the brain replacing the maladaptive movement-related pain 
memories.30 Another approach, directly targets to the increase of intraarticular and 
perisynovial concentrations of interleukin-10 and anti-inflammatory cytokine that 
protects chondrocites and may be responsible for the benefits for OA shown with 
exercise.31 However, there is a lack of evidence about which type, frequency, volume and 
intensity of exercise is better. 
PE combined with MT17 or with ET21 have shown to be better than education isolated for 
pain.17 Patients suffering some chronic pain condition used strategies to manage their pain 
and develop coping strategies, defined as the thoughts and actions in which people engage 
in their efforts to manage pain on a daily basis.32 Pain education tries to increase patients‘ 
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beliefs in their own ability to control their situation, and thereby potentially improve their 
coping strategy.33 
High quality evidence of studies showed that combined treatment with ET plus hot packs 
plus US is better than ET plus hot packs for intensity of pain at post-treatment and at one 
and three months of follow-up.26 However, the effectiveness of US combined with other 
techniques should be interpreted with caution as this is based on the significant benefits 
demonstrated by only one study. 
The results of our review on hip ROM showed high quality evidence that MT increases 
ROM in hip OA patients at post-treatment.15,25 Nevertheless, the effects of ET on hip 
ROM still remained unclear.34,35  
As previously was explained, MT might produce different effects on hip capsule and 
surrounding muscles that could explain the increase in hip ROM restoring the normal hip 
arthrokinematics.15,25 Estébanez-de-Miguel et al.,15 showed that a specific intensity of 
force mobilization appears to be necessary for increasing ROM in these patients.  
The effects of ET on the three planes of hip ROM are unclear,34,35 high quality evidence 
showed that exercise based on NW and strengthening exercises for hip and knee muscles 
improve different movements of hip ROM at post-treatment.18 The combination of MT 
and ET or PE showed no better benefits.16,17 This fact could be related with the interaction 
between both therapies or because the combined intervention spent less time on each 
intervention compared to isolated interventions.  
 
For physical function outcomes, high quality evidence reflected the benefits of ET and 
MT in isolation in any of the tests used in the studies.19,25 Combined therapies such as ET 
plus PE, showed better benefits than ET isolated.16  
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Improvements achieved in physical function by MT and ET are not explained clearly by 
the authors. Improvements achieved in pain intensity and ROM by MT and ET could be 
related to a better physical function. Although muscular training may contribute to a better 
physical function, it cannot be ruled out that improvements in hip ROM also played a role 
for improvements in functional performance.36 
Although ET and MT showed positive effects on physical function, their combination 
showed no better benefits. French et al.,16 suggested that these results were due to the fact 
that the intervention had not a psychological impact. These findings agree with high 
quality evidence that showed better benefits on physical function when ET was combined 
with PE.21 PE combined with ET could improve the coping strategy of the patients, which, 
in turn, could influence an improvement in physical function.37 Nevertheless, clinical 
guidelines recommend the combination of ET and MT,5 so further investigation is 
necessary to describe the effects of this intervention and the results of this study should 
be interpreted with caution.  
High quality evidence indicates that combined treatment with ET plus hot packs plus US 
is better than ET plus hot packs for physical function at post-treatment.26 It is assumed 
that US have thermal and mechanical effects on the target tissue resulting in an increased 
local metabolism, circulation, extensibility of connective tissue and tissue regeneration.38 
But the results are based on only one study and most of studies about US are poor quality 
and not well designed. Moreover, hot therapy applied to warm up the muscles for exercise 
might obtain positive effects.  
The results of the present review suggest that MT reduces pain, increases hip ROM and 
improves physical function in hip OA population in a short term. Our results also show 
that ET improves pain intensity and physical function and the combination of MT or ET 
with PE is beneficial in terms of improvement pain and physical function in hip OA 
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population in short and long term. These findings are in agreement with previous 
systematic reviews which found that MT improve physical function.39 Also, therapeutic 
exercise based on aquatic exercise have shown decreasing pain and improving physical 
function in short term40 and other approaches as Tai-Chi have shown decreasing pain and 
improving physical function in short and long term in hip and knee OA.41,42 However, a 
definitive conclusion cannot be made due to insufficient data and limitations of the 
studies.  
Given the demonstrated positive effects, we believe that non-pharmacological 
conservative treatment such as MT and ET will improve the prognosis of patients in the 
mild and moderate phases of hip OA. Also, the combination of MT and ET with other 
therapies like viscosupplementation could be a promising approach for hip OA.43 This 
has a very important clinical application, since if this approach is undertaken at an early 
stage it could delay progression of the hip OA and thereby prevent the need for surgery 
and avoid complications and risks.  
This review has several limitations. First, the heterogeneity of measurements and tools 
used to assess physical function, lack of power and internal and external validity of the 
studies. Second, although we conducted an extensive literature search because resources 
were limited we extracted data only from studies published in the English, Spanish and 
French language, potentially excluding other important evidence. And finally, we 
included only hip OA studies, previous reviews have included studies of OA affecting 
other joints as well which could explain the difference in the findings. 
 
5. Conclusion 
The result of this review provides high quality evidence that MT, ET and its combination 
with PE decrease pain and improve physical function in patients with hip OA. There is 
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high quality evidence that MT increases ROM in hip OA, However the effects of ET on 
hip ROM are unclear. The combination of MT plus ET needs further investigation to 
establish the effects. We are unable to make a definitive conclusion due to the insufficient 
studies and limitations listed previously. Future studies should consider better 
methodological aspects, therapies combined, homogeneous outcome measurements and 
analyse effect size. 
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Figure 1. Flowchart diagram.  
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Figure 2. Risk of bias across studies presented by percent that met the PEDro scale 
criteria. 
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Table 1. PEDro scores for included studies.  
 
*1, Elegibility criteria were specified.  
 Not calculated in overall score. 
 Out of ten; Y = criterion satisfied and N = criterion not satisfied. 
2, Subjects randomly allocated to groups. 
3, Allocation was concealed. 
4, Groups similar at baseline regarding most important prognostic indicators. 
5, Blinding of subjects. 
6, Blinding of all therapists. 
7, Blinding of all assessors who measured at least one key outcome.  
8, Measures of key outcomes obtained from more than 85% of those initially allocated to groups. 
9, All subjects for whom outcome measures were available received the treatment or control condition as 
allocated or where this was not the case, data was analysed by “intention to treat”.  
10, Results of between group statistical comparisons are reported for at least one key outcome. 
11, Study provides both point measures and measures of variability for at least one key outcome.
Reference Item 
Total 
Score 
Study 
quality 
 1 2 3 4 5 6 7 8 9 10 11   
Bennell et al.,22 Y Y Y Y Y N Y Y Y Y Y 9 High 
Poulsen et al.,17 Y Y Y Y N N Y Y Y Y Y 8 High 
Brantingham et al.,20 Y Y Y Y N N N Y Y Y Y 7 High 
Fernandes et al.,21 Y Y Y Y N N Y Y Y Y Y 8 High 
Köybasi et al.,26 Y Y Y Y Y N Y Y N Y Y 8 High 
Bieler et al.,18  Y Y Y Y N N Y N Y Y Y 7 High 
Bieler et al.,19 Y Y Y Y N N Y N Y Y Y 7 High 
Fukumoto et al.,23 Y Y N Y N N N N N Y Y 4 Poor 
Fukumoto et al.,24 Y Y N Y N N N N N Y Y 4 Poor 
French et al.,16 Y Y Y Y N N Y Y Y Y Y 8 High 
Estébanez de Miguel 
et al.,15 
Y Y N Y Y N Y Y Y Y Y 8 
High 
Beselga et al.,25  Y Y N Y Y N Y Y Y Y Y 8 High 
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Table 2. Results of the included studies. 
Study Sample (N) Intervention Total number of 
session /Frequency / 
Single session 
duration 
Variables Results (p-value) Follow-up time 
frame (p-value) 
Estébanez de 
Miguel et al.,15 
G1: 61.8 ± 9.6 
years 
(N=20) 
G2: 66 ± 9.5 years 
(N=20) 
 
G3: 61.1 ± 9.5 
years (N=20) 
G1: MT low force  
 
 
G2: MT medium force  
 
 
G3: MT high force  
3 sessions of 10 
minutes of duration 
each one.  
WOMAC pain, ROM 
 
 
Greater ROM after 
treatment in G3 
compared to G1 
(p<0.05). No 
differences were 
found between G2 
and G3 (p>0.05) 
 
Greater WOMAC 
pain was found in 
G1 (p=0.002) and 
G3 (p=0.03). No 
differences were 
found between 
groups in WOMAC 
pain (p>0.05) 
No data 
Bieler et al.,18 
 
 
G1:  69.6 ± 5.4 
years (N=50) 
 
G2:  70.0 ± 6.3 
years (N=50) 
 
G3: 69.3 ± 6.4 
years (N=52) 
G1: Strength training  
 
 
G2: Nordic Walking  
 
 
G3: Unsupervised home-based 
exercise  
12 sessions. 3 times 
weekly. Progressive 
strength training 1 
hour, 4 weeks 50% of 
maximum voluntary 
contraction to 75% of 
MVC 
NW 12-14 intensity on 
Borg scale. 3 km 4 
weeks to 4.3km. 
ROM No differences were 
found between 
groups after 
treatment  
(p>0.05) 
 
G1 improved 
external rotation 
ROM after treatment 
(p<0.05) 
 
G2 improved flexion 
ROM (p<0.01) and 
internal rotation 
No differences were 
found between 
groups at 4 and 12 
months follow-up  
(p>0.05) 
 
G1 improved 
external and internal 
rotation at 4 moths 
of follow- up  
 
G2 improved flexion 
ROM at 4 and 12 
months (p<0.05), 
external rotation at 
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(p<0.05) after 
treatment 
12 months (p<0.05) 
and internal rotation 
at 4 months (p<0.05) 
 
G3 improved 
internal and external 
rotation ROM at 4 
months of follow up 
(p<0.05) and 
external rotation at 
12 months (p<0.05) 
Bieler et al.,19 
 
 
G1:  69.6 ± 5.4 
years (N=50) 
 
G2: 70.0 ± 6.3 
years (N=50) 
 
G3: 69.3 ± 6.4 
years (N=52) 
G1: Strength training 
 
 
G2: Nordic Walking  
 
 
G3: Unsupervised home-based 
exercise  
12 sessions. 3 times 
weekly. 4 weeks. 
Progressive strength 
training 1 hour, 50% of 
maximum voluntary 
contraction to 75% of 
MVC 
NW 12-14 intensity on 
Borg scale. 3 km 4 
weeks to 4.3km. 
 
 
30CS,TSC, 6MWT, 
TUG, MOS, WOMAC  
 
No differences were 
found between 
groups in WOMAC 
pain and physical 
function (p>0.05) 
 
Greater physical 
function after 
treatment in G2 
compared to G1 and 
G3  (p<0.05)  
 
G1 improved TUG 
and MOS after 
treatment (p<0.05) 
 
 
Decreased WOMAC 
pain intensity in G2 
compared to G1 and 
G3 at 4 months 
follow-up (p<0.05) 
 
Greater physical 
function in G2 
compared to G1 and 
G3 at 4 and 12 
months follow-up  
(p<0.05)  
 
G1 improved 30CS 
and TUG at 4 
months of follow-
up. G3 improved 
30CS at 4 and 12 
months of follow up 
(p<0.05) and TUG at 
4 months (p<0.01). 
Fukumoto et 
al.,23 
 
G1: 51.9 ± 7.0 
years (N=15) 
 
G1: High-velocity resistance 
training  
 
Eight-week daily 
home-based resistance 
training programme. 
Two sets of 10 
VAS, HHS,  Greater HHS scores 
after treatment in G1 
(p<0.05) and G2 
(p<0.01). No 
 No data 
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G2: 53.1 ± 10.2 
years (N=17) 
 
G2: Low-velocity resistance 
training  
concentric and 
eccentric repetitions 2 
weeks. 3 sets 6 weeks. 
HVT as rapidly as 
possible and 3s 
eccentric phase. LHY 
3s concentric an 
eccentric phase 
differences were 
found between 
groups after 
treatment  
(p>0.05). 
 
G2 improvement 
VAS after treatment 
(p<0.05) 
Beselga et al.25 
 
 
G1: 78.3 ± 6.1 
years (N=20) 
 
G2: 77.5 ± 6.9 
years 
(N=20) 
G1: MT (Mobilization with 
movement)  
 
G2: Sham MT  
1 session. 3 series of 10 
repetitions each with 10 
minutes break.  
NRS, ROM, TUG, 
SPW, 30CS 
 
Greater ROM, 
physical function 
and less symptoms 
were found in G1 
(p<0.01) and the 
improvements were 
superior to G2 
(p<0.01). 
No data 
Bennell et al.,22 G1: 64.5 ± 8.6 
years 
(N=49) 
 
 
 
G2: 62.7 ± 6.4 
years 
(N = 53) 
G1: MT (hip thrust 
manipulation + hip-lumbar 
spine mobilization + deep tissue 
massage + stretching) + home 
exercises + education  
   
G2: Inactive ultrasounds  
10 sessions over 12 
weeks. Two initial 
sessions 45-60 minutes. 
The remainder 30 
minutes.  
VAS, WOMAC Greater physical 
function and less 
symptoms after 
treatment in the G1 
and G2 (p<0.05). No 
differences were 
found between 
groups (p<0.05). 
After 36 weeks there 
were no differences 
between groups 
(p<0.05). 
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Fukumuto et 
al.,24 
 
 
G1: 52.4 ± 9.2 
years (N=19) 
 
 
G2:  52.5 ± 10.1 
years (N=20) 
 
G1: High-velocity resistance 
training  
 
 
G2: Low-velocity resistance 
training  
Eight-week daily 
home-based resistance 
training programme. 
Two sets of 10 
concentric and 
eccentric repetitions 2 
weeks. 3 sets 6 weeks. 
HVT as rapidly as 
possible and 3s 
eccentric phase. LHY 
3s concentric an 
eccentric phase 
3MWT, TUG, HHS, 
VAS 
Greater physical 
function after 
treatment in G1 
respect G2 (p<0.05)  
 
No differences were 
found in the rest of 
variables between 
groups after 
treatment  
(p>0.05) 
 
No data 
French et al.16  G1: 62.44 ± 9.09 
years 
(N=43) 
 
G2: 61.43 ± 10.7 
years 
(N=45) 
 
G3: No data 
(N=43) 
G1: Therapeutic exercise  
 
 
 
G2: Therapeutic exercise + 
Manual therapy (translatory or 
rotatory techniques)  
 
G3: control  
Therapeutic exercise 6 
to 8 individual sessions 
over 8 weeks. 30 
minutes.  
 
15 minutes of manual 
therapy for G2.   
WOMAC, NRS, SF-
36, ROM, 5 times sit to 
stand, 50 foot-walk test 
No differences were 
found between G1 
and G2 for any 
variables (p>0.05) 
 
Greater ROM, 
WOMAC and 
physical function in 
G1 and G2 
compared to G3 
(p<0.05) 
 
No differences were 
found in G1 and G2 
compared to G3 for 
the rest variables 
(p>0.05) 
 
No differences were 
found between G1 
and G2 18 weeks 
follow-up (p>0.05) 
 
Poulsen, et al.,17 G1: 65.5 ± 7.3 
years 
(N=37) 
 
G2: 65.8 ± 8.5 
years 
G1: Patient Education (home 
stretching exercises) 
 
 
G2: MT (trigger point release 
therapy + muscular stretching + 
5 sessions (45 to 90 
minutes)  
 
 
NRS, ROM, HOOS 
pain, HOOS ADL, 
HOOS QoL, 
G2 showed better 
outcomes in HOOS 
pain and quality of 
life respect G1 and 
G3 (p>0.05)  
 
The improvements 
in G2 are maintained 
at 12 weeks follow-
up (p<0.05) 
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(N=38) 
 
 
G3: 62.5 ± 9.4 
years 
(N=36) 
joint manipulation) + Patient 
Education  
 
G3: Control  
12 sessions. 2 times a 
week. 6 weeks. 15 – 25 
minutes 
 
 
1 session. 5 to 10 
minutes.  
G2 showed better 
outcomes for NRS 
and HOOS respect 
G3 (p<0.05) 
 
No differences were 
found between 
groups in the rest of 
variables (p>0.05) 
Brantingham et 
al.,20 
G1: 62.8 ± 10.3 
years (N=58) 
 
G2: 63.3 ± 10.7 
years (N=53) 
G1: MMT (Hip HVLA 
manipulation) + exercise  
 
G2: Kinematic chain MMT 
(low back, hip, knee and ankle 
HVLA manipulation) + exercise  
 
9 treatments over a 5 – 
week period. 30 
minutes each session.  
WOMAC, HHS 
 
No differences were 
found between 
groups after 
treatment (p>0.05) 
No differences were 
found between 
groups 3 months 
follow-up  
(p>0.05) 
Fernandes et 
al.,21 
G1: 57.2 ± 9.8 
years (N=54) 
 
G2: 58.4 ± 10.0 
years (N=55) 
G1: Patient education  
 
G2: Patient education + 
supervised exercise 
(strengthening, functional and 
flexibility exercises)  
PE comprised 3 group 
sessions and one 
individual 2 months 
later. Exercise therapy 
started a week after 
completing the 
education sessions 
twice a week for 12 
weeks.  
WOMAC pain, 
WOMAC physical 
function, SF-36 
 
No differences were 
found between 
groups in WOMAC 
pain after 4 months.  
(p>0.05) 
 
No differences were 
found between 
groups in SF-36 after 
4 months (p>0,05) 
 
Greater WOMAC 
physical function 
was found in G2 
compared to G1 after 
10 and 16 months 
(p=0.01) 
 
No differences were 
found between 
groups in WOMAC 
pain at 10 and 16 
months follow-up 
(p>0.05) 
 
No differences were 
found between 
groups in SF-36 after 
10 and 16 months 
(p>0,05) 
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Köybasi et al.,26 G1: 64.3 ± 6.0 
years (N=15) 
 
G2: 64.9 ± 6.0 
years 
(N=15) 
 
G3: 66.9 ± 8.2 
years 
(N=15) 
G1: Exercise + hot packs  
 
 
G2: Exercise + hot packs + 
sham US 
 
 
G3: Exercise + hot packs + US  
2 weeks 5 session per 
week. 
Hot packs for 20 
minutes before therapy. 
20 minutes of 
strengthening and 
lengthening exercises 
VAS on activity, VAS 
rest, WOMAC, 15-m 
timed walking test 
 
 
 
 
 
Decreased pain 
intensity and greater 
physical function in 
G1, G2 and G3 
(p<0.05) and G3 
showed after 
treatment better 
outcomes in VAS 
and WOMAC than 
G1 and G2 (p<0.01) 
 
 
The improvements 
were better in G3 
than G2 and G1 in 
pain intensity and 
WOMAC 
questionnaire and 
physical function 
measurement by 15 
timed walking test at 
1 and 3 months of 
follow-up. 
 (p<0.001) 
3MWT: 3 Minutes Walking Test; 6MWT: 6 Minutes Walking Test; 30CS: 30 seconds chair to stand; AD: Activities of daily living; G: Group; HOOS: Hip Osteoarthritis 
Outcome Scale; HHS: Harris Hip Score; HVLA: High Velocity Low Amplitude; MMT: Manual and Manipulative Therapy; MOS: 15 second Marching on the Spot test; MT: 
Manual Therapy; NPRS: Numerical Pain Rating Score; NRS: Numerical Rating Score; PE: Patient Education; QoL: Quality of life; ROM: Range of Motion; SF-36: The Short 
Form Health Survey; SPW: 40 meters Self-Placed; TSC: Timed Stair Climbing Test; TUG: Timed Up and Go; US: Ultrasounds; VAS: Visual Analogic Scale; WOMAC: 
Western Ontario and McMaster Universities Osteoarthritis Index. 
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Table 3. Data effect size between groups. 
Study Variable Effect size (95% CIs) 
Fukmoto et al.,24 
 
 High-velocity resistance training (G1) VS 
Low-velocity resistance training (G2) 
 
  
HHS 
VAS 
0.01 (-6.7 to 7.0) 
0.10 (-14.8 to 11.3) 
 
Beselga et al.,25 
 
 
 
NPRS 
Hip ROM 
 Flexion 
 IR 
TUG 
30CS 
SPW 
MT (Mobilization with 
movement) VS Sham 
 
1.9 
 
3.0 
1.4 
1.0 
1.7 
1.5 
  
Poulsen, et al.,17  
 
 
 
NRS 
HOOS 
 HOOS Pain 
 HOOS symptoms 
 HOOS function ADL 
 HOOS QoL 
Hip ROM 
 Flexion 
 Abd-add 
IR-ER 
Patient Education (home stretching 
exercises) VS Control 
 
 
-0.02 (-0.49 to 0.46) 
 
0.01 (-0.47 to 0.49) 
-0.13 (-0.61 to 0.34) 
-0.05 (-0.53 to 0.42) 
0.04 (-0.44 to 0.52) 
 
-0.54 (-1.03 to 0.04) 
-0.29 (-0.77 to 0.20) 
-0.29 (-0.78 to 0.20) 
MT (trigger point release therapy + muscular 
stretching + joint manipulation) + Patient 
Education VS Control 
 
-0.92 (-1.42 to -0.41) 
 
1.08 (0.56 to 1.59) 
0.75 (0.25 to 1.25) 
0.85 (0.34 to 1.36) 
0.88 (0.37 to 1.38) 
 
-0.26 (-0.75 to 0.23) 
0.25 (-0.25 to 0.74) 
-0.28 (-0.78 to 0.22) 
Fernandes et 
al.,21 
 
 
 
WOMAC pain 4 months 
                       10 months  
Patient education VS Patient education + 
supervised exercise (strengthening, 
functional and flexibility exercises) 
-0.26 (-0.64 to 0.11) 
-0.35 (-0.77 to 0.07) 
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                       16 months 
WOMAC physical function 4 months 
                                            10 months  
                                            16 months 
-0.30 (-0.75 to 0.15) 
-0.29 (-0.67 to 0.09) 
-0.48 (-0.91 to 0.06) 
-0.47 (-0.93 to -0.02) 
Abbreviations: 30CS: 30 seconds chair to stand; HHS: Harris Hip Score; HOOS: Hip Osteoarthritis Outcome Scale; NPRS: Numeric Pain Rating Score; NRS: Numeric Rating 
Score; ROM: Range of motion; SPW: 40 meters Self-Placed; TUG: Timed Up and Go; VAS: Visual Analogic Scale.  
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Appendix 1. Search strategy.  
MEDLINE (Pubmed) database: "osteoarthritis, hip"[MeSH Terms] AND (("physical therapy modalities"[MeSH Terms] OR ("physical"[All Fields] 
AND "therapy"[All Fields] AND "modalities"[All Fields]) OR "physical therapy modalities"[All Fields]) OR ("combined modality therapy"[MeSH 
Terms] OR ("combined"[All Fields] AND "modality"[All Fields] AND "therapy"[All Fields]) OR "combined modality therapy"[All Fields]) OR 
"therapeutics"[MeSH Terms])  
 
Cochrane database: (hip osteoarthritis) AND (physical therapy modalities OR combined modality therapy OR therapeutics): ("osteoarthritis, 
hip"[MeSH Terms] OR ("osteoarthritis"[All Fields] AND "hip"[All Fields]) OR "hip osteoarthritis"[All Fields] OR ("hip"[All Fields] AND 
"osteoarthritis"[All Fields])) AND (("physical therapy modalities"[MeSH Terms] OR ("physical"[All Fields] AND "therapy"[All Fields] AND 
"modalities"[All Fields]) OR "physical therapy modalities"[All Fields]) OR ("combined modality therapy"[MeSH Terms] OR ("combined"[All 
Fields] AND "modality"[All Fields] AND "therapy"[All Fields]) OR "combined modality therapy"[All Fields]) OR ("therapeutics"[MeSH Terms] 
OR "therapeutics"[All Fields])) 
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Scopus database: (“hip osteoarthritis”[MeSH Terms]) AND “physical therapy modalities”[MeSH Terms]: "osteoarthritis, hip"[MeSH Terms] AND 
"physical therapy modalities"[MeSH Terms] 
 
PEDro database: “hip osteoarthritis”: "osteoarthritis, hip"[MeSH Terms] 
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participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
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INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  Page 1-2 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
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Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
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and 
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Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
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Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators.  
Page 3 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
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Risk of bias in individual 
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done at the study or outcome level), and how this information is to be used in any data synthesis.  
Page 4-5 
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(e.g., I2) for each meta-analysis.  
Page 5 
 
Page 1 of 2  
Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
Fig 2 and 
Table 1 
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which were pre-specified.  
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Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  Page 6 
and Fig.2 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
Pag 8-9 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  Table 2-3 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  Page 6 
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DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
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